Meet BacVax: a PBC startup working on a vaccine to prevent ear infections in young children.
Dr. Terrence Stull’s company, called BacVax, is developing a vaccine to prevent ear infections in young children.
BacVax is a University of Arizona spinoff founded by Stull, former senior vice president of research at Phoenix Children’s Hospital.
BacVax uses molecular genetics to study Haemophilus influenzae, a common cause of ear infections. Stull moved his startup from the University of Arizona College of Medicine – Phoenix to 850 PBC on the Phoenix Bioscience Core in July 2021, noting the building is a prime location to grow and expand.
Related reading:
Check out the new Connect Labs at 850 PBC, opening in just a few short weeks.
Check out the video below and read more about BacVax here on the Arizona PBS website as part of its Health Tomorrow segment, supported by the Phoenix Bioscience Core.
More news from the PBC
- Connecticut mom finds healing and hope after cross-country journey to undergo rare spinal surgery in Arizona to remove dangerous malformation
- TGen appoints Nhan L. Tran, Ph.D., to faculty as distinguished professor
- Convocation Marks Class of 2026’s Final Step Toward Their Careers in Medicine
- Internationally recognized oncology drug development leader and melanoma expert joins HonorHealth Research Institute
- Google selects U of A for quantum research group focused on life sciences
- New TGen Clinical Test for Multiple Myeloma Consolidates Multiple Analyses and Provides Detailed Information in 3 Days
- HonorHealth Research Institute explores a new way to treat type 2 diabetes without drugs